Experience with Thiomerin, A New Mercurial Diuretic

Abstract

Thiomerin, a new mercurial diuretic, was given subcutaneously to 109 patients in whom fluid accumulations were present. Most patients suffered from congestive heart failure. It was used first under close supervision in hospitalized patients and later in ambulatory patients. In certain patients it was possible to compare the diuretic response to Thiomerin given subcutaneously with that to Mercuzanthin and/or Mercuhydrin given intramuscularly or intravenously. The untoward effects of these mercurial diuretics were compared with those caused by Thiomerin. The advantages of a subcutaneous mercurial diuretic are pointed out.